礼来去年营收增三成:减重替尔泊肽收入近50亿美元,四季度销售不及预期

澎湃新闻
06 Feb

在明星品种替尔泊肽的助力下,礼来2024年业绩大涨。当地时间2月6日,美国礼来公司(LLY.US)发布2024年财报,全年营收450.43亿美元,同比增长32%,与今年1月公布的全年业绩预期相符;全年净利润(非GAAP)为105.9亿美元,同比增长102%。单季度来看,2024年第四季度礼来收入为135.33亿美元,同比增长45%;净利润为44.1亿美元,同比增长101%。礼来2024年财务数据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10